Register to view the archived recording here.
UMMS Taps Four-Person Board to Head Planned RNA Therapeutics Institute
In addition to assigning responsibility of the institute to the four-member group, rather than a single director, UMMS has also expanded the center's focus to include all RNA therapeutics, not just ones based on RNAi.
New to GenomeWeb? Register here quickly.